Table 1.
Zones of inhibition (mm) of synthesized compounds (1 mg/mL), ciprofloxacin, and metronidazole against clinical strains of H. pylori (1–12) and control strain.
| Tested Compound | Zones of Inhibition (mm) | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Clinical Isolates | Control Strain | ||||||||||||
| 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | ||
| 3a | 10 | 20 | 15 | 10 | 20 | 11 | 11 | 17 | 9 | 15 | 13 | 15 | 18 |
| 3b | 12 | 12 | 0 | 15 | 11 | 16 | 13 | 15 | 11 | 12 | 14 | 13 | 12 |
| 3c | 20 | 24 | 20 | 16 | 24 | 20 | 18 | 25 | 15 | 20 | 23 | 25 | 25 |
| 3d | 10 | 10 | 8 | 12 | 13 | 11 | 14 | 15 | 9 | 14 | 13 | 12 | 12 |
| 3e | 10 | 12 | 0 | 15 | 15 | 14 | 12 | 16 | 9 | 15 | 15 | 14 | 13 |
| CIP | 20 | 40 | 0 | 40 | 50 | 45 | 50 | 0 | 0 | 45 | 50 | 45 | 45 |
| MTZ | 10 | 0 | 0 | 0 | 0 | 10 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| DMSO | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
CIP: ciprofloxacin; MTZ: metronidazole.